Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5091982
Max Phase: Preclinical
Molecular Formula: C29H45BrO4
Molecular Weight: 537.58
Molecule Type: Unknown
Associated Items:
ID: ALA5091982
Max Phase: Preclinical
Molecular Formula: C29H45BrO4
Molecular Weight: 537.58
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=C[C@]1(C)C[C@@H](O)[C@]2(C)[C@H](C)CC[C@]3(CC(=C)C(=O)[C@H]32)[C@@H](C)[C@@H]1OC(=O)CCCCCCCBr
Standard InChI: InChI=1S/C29H45BrO4/c1-7-27(5)18-22(31)28(6)20(3)14-15-29(17-19(2)24(33)25(28)29)21(4)26(27)34-23(32)13-11-9-8-10-12-16-30/h7,20-22,25-26,31H,1-2,8-18H2,3-6H3/t20-,21+,22-,25+,26+,27-,28+,29+/m1/s1
Standard InChI Key: FXQDMYFPCNIKTE-JRCAEBEASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 537.58 | Molecular Weight (Monoisotopic): 536.2501 | AlogP: 6.79 | #Rotatable Bonds: 9 |
Polar Surface Area: 63.60 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 6.89 | CX LogD: 6.89 |
Aromatic Rings: 0 | Heavy Atoms: 34 | QED Weighted: 0.12 | Np Likeness Score: 1.95 |
1. Zhang K, Song W, Wei M, Sun Y, Wang N, Ma L, Yu X, Gao R, Wang R, Zhang Y, Zheng N, Li N, Mu L, Tang Z, Li X, Yang C, Yang G.. (2021) A Novel Anticancer Stem Cell Compound Derived from Pleuromutilin Induced Necroptosis of Melanoma Cells., 64 (21.0): [PMID:34704758] [10.1021/acs.jmedchem.1c01123] |
Source(1):